Renal and neurological side effects of colistin in critically ill patients

Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model

(2010) J. B. Bulitta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital

(2010) C. A. DeRyke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration

(2010) Roberto Imberti et al.   CHEST

Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator‐Associated Pneumonia: A Matched Case‐Control Study

(2010) Diamantis P. Kofteridis et al.   CLINICAL INFECTIOUS DISEASES

Predictors of acute kidney injury associated with intravenous colistin treatment

(2010) Jeong-Ah Kwon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections

(2010) Chien-Yu Cheng et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Risk factors for colistin-associated nephrotoxicity

(2010) Pinyo Rattanaumpawan et al.   JOURNAL OF INFECTION

Intravenous colistin sulfate: A rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections

(2010) Jie Huang et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

(2009) D. Plachouras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center

(2009) Joshua D. Hartzell et al.   CLINICAL INFECTIOUS DISEASES

Prevention of acute kidney injury and protection of renal function in the intensive care unit

(2009) Michael Joannidis et al.   INTENSIVE CARE MEDICINE

Clinical characteristics and risk factors of colistin-induced nephrotoxicity

(2009) Jieun Kim et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

(2009) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study

(2008) Nikolaos Markou et al.   CLINICAL THERAPEUTICS

Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii

(2008) Joon Young Song et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model

(2008) P. J. Bergen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria

(2008) Vicente Pintado et al.   JOURNAL OF INFECTION

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

(2008) Alex P. Betrosian et al.   JOURNAL OF INFECTION